GENOMIC STABILITY AND WILD-TYPE P53 FUNCTION OF LYMPHOBLASTOID-CELLS WITH GERM-LINE P53 MUTATION

被引:0
|
作者
LALLE, P
MOYRETLALLE, C
WANG, Q
VIALLE, JM
NAVARRO, C
BRESSACDEPAILLERETS, B
MAGAUD, JP
OZTURK, M
机构
[1] CTR LEON BERARD, INSERM, CJF 9302, ONCOL MOLEC LAB, F-69373 LYON 08, FRANCE
[2] HOP EDOUARD HERRIOT, INSERM, CJF 9307, CENT HEMATOL & CYTOGENET LAB, F-69437 LYON, FRANCE
[3] INST GUSTAVE ROUSSY, DIAGNOST MOLEC LAB, F-94805 VILLEJUIF, FRANCE
关键词
P53; LI-FRAUMENI SYNDROME; EPSTEIN-BARR VIRUS; LYMPHOBLASTOID CELLS; GENOMIC STABILITY;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Increased cancer risk associated with germ-line p53 mutation was linked to a deficit in the ability to maintain genomic stability. Accordingly, normal fibroblasts from cancer-prone individuals accumulate genomic aberrations with concomitant loss of mild-type p53 allele during in vitro culture. We tested whether such changes also occur in EBV-immortalized lymphoblastoid cells. Both normal and p53 germ-line mutant lymphoblastoid cells maintained functional p53 and genomic stability during long term in vitro culture. These unexpected differences between fibroblastic and lymphoblastic cells suggest that phenotypic expression of p53 deficiency is cell type specific. This could contribute to selective tissular localization of tumours observed in patients with Li-Fraumeni syndrome despite the presence of a mutant p53 allele in all cells.
引用
收藏
页码:2447 / 2454
页数:8
相关论文
共 50 条
  • [21] WILD-TYPE P53 INDUCED APOPTOSIS IN A BURKITT-LYMPHOMA (BL) LINE THAT CARRIES MUTANT P53
    RAMQVIST, T
    MAGNUSSON, KP
    WANG, YS
    SZEKELY, L
    KLEIN, G
    WIMAN, KG
    ONCOGENE, 1993, 8 (06) : 1495 - 1500
  • [22] Targeted point mutations of p53 lead to dominant-negative inhibition of wild-type p53 function
    de Vries, A
    Flores, ER
    Miranda, B
    Hsieh, HM
    van Oostrom, CTM
    Sage, J
    Jacks, T
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2002, 99 (05) : 2948 - 2953
  • [23] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    A Vinyals
    M A Peinado
    M Gonzalez-Garrigues
    M Monzó
    R D Bonfil
    A Fabra
    Gene Therapy, 1999, 6 : 22 - 33
  • [24] Failure of wild-type p53 gene therapy in human cancer cells expressing a mutant p53 protein
    Vinyals, A
    Peinado, MA
    Gonzalez-Garrigues, M
    Monzó, M
    Bonfil, RD
    Fabra, A
    GENE THERAPY, 1999, 6 (01) : 22 - 33
  • [25] Wild-type p53 triggers a rapid senescence program in human tumor cells lacking functional p53
    Sugrue, MM
    Shin, DY
    Lee, SW
    Aaronson, SA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (18) : 9648 - 9653
  • [26] Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53
    Li, PX
    Bui, T
    Gray, D
    Klamut, HJ
    BREAST CANCER RESEARCH AND TREATMENT, 1998, 48 (03) : 273 - 286
  • [27] Induction of wild-type p53 activity in human cancer cells by ribozymes that repair mutant p53 transcripts
    Watanabe, T
    Sullenger, BA
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (15) : 8490 - 8494
  • [28] The interaction between p53 and DNA topoisomerase I is regulated differently in cells with wild-type and mutant p53
    Gobert, C
    Skladanowski, A
    Larsen, AK
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1999, 96 (18) : 10355 - 10360
  • [29] Therapeutic potential of recombinant p53 overexpression in breast cancer cells expressing endogenous wild-type p53
    Peixiang Li
    Thuy Bui
    Dawn Gray
    Henry J. Klamut
    Breast Cancer Research and Treatment, 1998, 48 : 273 - 286
  • [30] The Inhibition of Autophagy Sensitises Colon Cancer Cells with Wild-Type p53 but Not Mutant p53 to Topotecan Treatment
    Li, Dan-Dan
    Sun, Ting
    Wu, Xiao-Qi
    Chen, Shu-Peng
    Deng, Rong
    Jiang, Shan
    Feng, Gong-Kan
    Pan, Jing-Xuan
    Zhang, Xiao-Shi
    Zeng, Yi-Xin
    Zhu, Xiao-Feng
    PLOS ONE, 2012, 7 (09):